Stemcelline Vial - UC Xeno - Free Mesenchymal cells
100 million in 5ml
The majority of MSC applications include the therapy of immune- and inflammation-mediated disorders as well as tissue degradation, with MSCs showing significant promise for the treatment of incurable diseases.
Fetal bovine serum (FBS), a popular supplement for cell growth but also a potential risk for transmission of infections obtained from animals, is a component of conventional MSC cultures.
How are we different?
- The health and medicine use of the donor is just two factors that affect the quality of MSCs.
- The quantity of MSCs recovered from older individuals is often modest since in vivo MSC synthesis declines with age. Therefore, creating a technique that consistently provides high MSCs is crucial for cell therapy.
The possibility of safe usage in human clinical therapy was demonstrated using xeno-free media. A xeno-free medium must be studied before being used for MSC cultures since these xeno-free media have various effects on MSCs.
To find a common cultural setting for all of these MSC sources, we experimented with a commercial xeno-free. The cells’ population doubling times (P2 to P6) and the expression of surface markers were examined.
We found two medium candidates that supported the isolation and culture of UC-MSCs using UC as the main screening. MSCs produced from BM and AD can also grow in these environments. The cells might develop into chondrocyte, adipocyte, and osteoblast/osteocyte lineages.
In order to determine the safety and viability of using UC-MSCs to treat bronchopulmonary dysplasia and chronic obstructive pulmonary disease, we are now undertaking a phase 1 clinical investigation.